Paul Beringer at University of Southern California - Research Interests, Publications & Academic Profile

Paul Beringer

Professor and Chair

University of Southern California

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

80%

Pharmacotherapy

60%

Pharmacokinetic

50%

Drug Safety

30%

Pharmacometrics

20%

Dose Optimization

20%

Antimicrobial Peptide

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications

Article Link

Year:

2023

Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients

Article Link

Year:

2023

Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: mechanistic exploration through physiologically-based pharmacokinetic modeling and a clinical case series.

Article Link

Year:

2023

Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria.

Article Link

Year:

2022

Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19.

Article Link

Year:

2022

Preclinical Pharmacokinetics and Safety of Intravenous RTD-1.

Article Link

Year:

2022

Chemical Synthesis of a Potent Antimicrobial Peptide Murepavadin Using a Tandem Native Chemical Ligation/Desulfurization Reaction.

Article Link

Year:

2021

Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer.

Article Link

Year:

2021

Anti-Inflammatory Effects of RTD-1 in a Murine Model of Chronic <i>Pseudomonas aeruginosa</i> Lung Infection: Inhibition of NF-κB, Inflammasome Gene Expression, and Pro-IL-1β Biosynthesis

Article Link

Year:

2021

Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity.

Article Link

Year:

2021

Collaborators3

Julio A. Camarero

University of Southern California

UNITED STATES

Eunjin Hong

University of Southern California

UNITED STATES

J. Neman

UNITED STATES

How do Indian students reach out?

Meet Kite AI